Literature DB >> 11849309

Tumour necrosis factor in mouse models of chronic intestinal inflammation.

Christoph Mueller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11849309      PMCID： PMC1782643          DOI： 10.1046/j.1365-2567.2002.01329.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  63 in total

1.  Infliximab for the treatment of fistulas in patients with Crohn's disease.

Authors:  D H Present; P Rutgeerts; S Targan; S B Hanauer; L Mayer; R A van Hogezand; D K Podolsky; B E Sands; T Braakman; K L DeWoody; T F Schaible; S J van Deventer
Journal:  N Engl J Med       Date:  1999-05-06       Impact factor: 91.245

Review 2.  Regulation of autoimmunity by proinflammatory cytokines.

Authors:  A P Cope
Journal:  Curr Opin Immunol       Date:  1998-12       Impact factor: 7.486

3.  Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.

Authors:  D Kontoyiannis; M Pasparakis; T T Pizarro; F Cominelli; G Kollias
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

4.  TNF-induced enterocyte apoptosis and detachment in mice: induction of caspases and prevention by a caspase inhibitor, ZVAD-fmk.

Authors:  P F Piguet; C Vesin; Y Donati; C Barazzone
Journal:  Lab Invest       Date:  1999-04       Impact factor: 5.662

5.  Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta.

Authors:  X Yang; J J Letterio; R J Lechleider; L Chen; R Hayman; H Gu; A B Roberts; C Deng
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

6.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

Authors:  K Takeda; B E Clausen; T Kaisho; T Tsujimura; N Terada; I Förster; S Akira
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

7.  Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens.

Authors:  S Wirtz; S Finotto; S Kanzler; A W Lohse; M Blessing; H A Lehr; P R Galle; M F Neurath
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

8.  Expression of the neutrophil chemokine KC in the colon of mice with enterocolitis and by intestinal epithelial cell lines: effects of flora and proinflammatory cytokines.

Authors:  F Song; K Ito; T L Denning; D Kuninger; J Papaconstantinou; W Gourley; G Klimpel; E Balish; J Hokanson; P B Ernst
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

9.  TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53.

Authors:  P F Piguet; C Vesin; J Guo; Y Donati; C Barazzone
Journal:  Eur J Immunol       Date:  1998-11       Impact factor: 5.532

10.  Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing.

Authors:  K M Mohler; P R Sleath; J N Fitzner; D P Cerretti; M Alderson; S S Kerwar; D S Torrance; C Otten-Evans; T Greenstreet; K Weerawarna
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962
View more
  16 in total

Review 1.  Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.

Authors:  Madharasi V A Pichai; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

Review 2.  Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease.

Authors:  D S A Sanders
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

Review 3.  A meta-analysis of the therapeutic effects of tumor necrosis factor-α blockers on ulcerative colitis.

Authors:  Xuan Huang; Bin Lv; Hai-Feng Jin; Shuo Zhang
Journal:  Eur J Clin Pharmacol       Date:  2011-06-21       Impact factor: 2.953

4.  Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease.

Authors:  Christina Kriegel; Mansoor Amiji
Journal:  J Control Release       Date:  2010-10-17       Impact factor: 9.776

Review 5.  Recent advances in development of nano-carriers for immunogene therapy in various complex disorders.

Authors:  Sanaz Shahgordi; Fatemeh Oroojalian; Ezzat Hashemi; Maryam Hashemi
Journal:  Iran J Basic Med Sci       Date:  2022-02       Impact factor: 2.532

6.  The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea.

Authors:  Kathrin Endt; Bärbel Stecher; Samuel Chaffron; Emma Slack; Nicolas Tchitchek; Arndt Benecke; Laurye Van Maele; Jean-Claude Sirard; Andreas J Mueller; Mathias Heikenwalder; Andrew J Macpherson; Richard Strugnell; Christian von Mering; Wolf-Dietrich Hardt
Journal:  PLoS Pathog       Date:  2010-09-09       Impact factor: 6.823

7.  The Intersection of TNF, IBD and the Microbiome.

Authors:  Yava L Jones-Hall; Cindy H Nakatsu
Journal:  Gut Microbes       Date:  2016

8.  Adiponectin deficiency modulates adhesion molecules expression and cytokine production but does not affect disease severity in the transfer model of colitis.

Authors:  Melissa E Gove; Maria Pini; Raja Fayad; Robert J Cabay; Giamila Fantuzzi
Journal:  Cytokine       Date:  2009-06-10       Impact factor: 3.861

9.  Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease.

Authors:  Christina Kriegel; Mansoor M Amiji
Journal:  Clin Transl Gastroenterol       Date:  2011-03-24       Impact factor: 4.488

10.  Impact of Interleukin 10 Deficiency on Intestinal Epithelium Responses to Inflammatory Signals.

Authors:  Stamatia Papoutsopoulou; Liam Pollock; Catherine Walker; William Tench; Sakim Shakh Samad; François Bergey; Luca Lenzi; Raheleh Sheibani-Tezerji; Phillip Rosenstiel; Mohammad Tauqeer Alam; Vitor A P Martins Dos Santos; Werner Müller; Barry J Campbell
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.